Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
Aardvark, AbbVie, AbCellera, Acceleron, advocacy, AE, AEs, African, Alaska, Alexion, Altimmune, Anderson, Arrowhead, ASCO, AstraZeneca, baseline, Bayer, begun, benchmark, benign, beta, BeyondSpring, big, biography, BioHaven, bisexual, Black, Boston, bundled, Burst, BYSI, Canada, Capsule, castrate, Cayman, CE, CELU, Chase, Chaudhari, CI, CNH, comfortably, Conformit, COVIDROPSTM, COVISHIELD, COVISHIELDTM, COVISTIX, COVITRACK, Cox, CPA, CPRA, CTCL, culminating, cum, Czerepak, DAS, DCTH, Delcath, delta, Deverra, Dicerna, disinfection, diversification, Dohme, driver, duloxetine, economy, Elizabeth, Elsie, English, era, ESG, esophageal, expedite, extracorporeal, faulty, female, fibromyalgia, fibrotic, fine, FINRA, fit, fold, foregone, frank, Fresno, Gateway, gay, GeneMAb, Genevant, gold, GX, Hangzhou, Hawaiian, hazard, headquartered, hearing, Heron, Hispanic, hydrochloride, IBRX, Icahn, ideally, inaccuracy, incredibly, indeterminate, instillation, interventional, Isarna, Islander, IVD, job, JPMorgan, judgement, KGaA, Koseido, labor, Landlord, Latino, laude, lean, leap, leg, lesbian, leukemia, lifted, lipid, LLJ, LS, lymphoblastic, magna, main, MD, mechanical, Merck, meteoric, metric, Michael, milnacipran, Mirati, mistake, Moderna, Mount, myelinated, naltrexone, NASD, Native, needle, Nektar, neurosensory, NSCLC, OA, ODI, omicron, ophthalmic, opposition, Oswestry, OVA, Ovalbumin, overnight, oxygen, oxygenation, Pfizer, Ph, pharmacy, PK, platinum, plutavimab, pregabalin, Prescient, Prominent, prostate, PtNC, quarantine, Quidel, quota, RA, recalculating, referenced, refinancing, Rehco, remarkable, rentable, reply, rooted, roughly, RSU, Sabatina, Sachin, samtonadstrocel, SB, Score, SE, seasoned, secondary, sector, Senator, sentence, Sharp, sick, Sinai, soft, Spanish, SPPI, subsidiarity, succeeded, surge, suspected, Takeda, tender, thinly, ticker, Tien, transgender, Twist, underrepresented, unjustly, unmyelinated, VCDPA, ventilation, versatile, VH, VIE, Virex, Virginia, VoC, volunteer, Wainwright, weather, week, WKSI, Women, Zhejiang
Removed:
accessible, addressing, affiliated, appoint, BDL, Center, convenient, declared, discharge, division, dosed, DoseDisc, expressing, faith, feasibility, federally, hope, Japanese, Mine, narrative, nominate, owing, prepaid, promised, recording, registering, replicated, resale, retrospective, retrospectively, scenario, Shao, step, supplementally, thirty, TSRI, undelivered, Unresolved, wearable
Filing tables
Filing exhibits
SRNE similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-163670, 333-198307, 333-213130, 333-227305, 333-234622, 333-249616 and 333-249617 on Form S-8 and Registration Statement Nos. 333-223856, 333-223857, 333-228770, 333-229609, 333-232163, 333-234869, 333-235970, 333-237142, 333-249178, 333-249386, 333-253646, 333-255165, 333-256304, 333-257412 and 333-261888 on Form S-3 of our report dated March 2, 2020, relating to the financial statements of Sorrento Therapeutics, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.
/s/ Deloitte & Touche LLP
San Diego, California
March 11, 2022